“Clinically tested,” “24-hour hydration,” “visibly smoother in four weeks,” and “90% agreed skin looked brighter” sound similar on a product page. They are not the same kind of claim, and they should not come from the same kind of evidence.
One may require an instrument that measures skin hydration over time. Another may come from trained visual grading or standardized imaging. A percentage-agreement statement usually reflects a consumer questionnaire. Laboratory work on isolated cells may explain a mechanism, but it does not automatically prove that people will see the same benefit from the finished product.
For skincare founders, claims testing is most efficient when it begins before the formula and marketing copy are final. The desired message determines the study design; the study design influences budget, timeline, packaging, directions, and sometimes the formula itself.
Start With the Exact Claim, Not the Test Menu
Testing laboratories offer many methods, but choosing a device first can produce data that does not answer the brand’s actual marketing question. “Hydrates” might refer to an immediate increase in stratum-corneum hydration, a benefit lasting through a defined number of hours, improved user perception after repeated use, or a softer-looking surface in photography. Those are related, but not identical.
Write the proposed claim in plain language, including the population, body area, amount, frequency, comparison, and time point. Then ask what outcome would make that sentence true. A claim such as “improves skin hydration for eight hours after one use” points toward repeated instrumental measurements after controlled application. “Skin feels more comfortable after two weeks” points toward a consumer-perception endpoint with a defined questionnaire and use protocol.
Claims can be express or implied
Founders often review only the literal words. Regulators and consumers can also interpret the overall message created by images, product name, comparisons, charts, testimonials, and context. A dramatic close-up, a white-coat visual, or “studies show” language may imply a stronger level of support than the small print describes.
The Federal Trade Commission’s advertising-substantiation policy states that advertisers should have a reasonable basis for objective express and implied claims before dissemination. FDA separately requires cosmetic labeling claims to be truthful and not misleading and treats disease or structure/function claims as drug claims. Testing should therefore be planned alongside claim wording and regulatory review, not used afterward to rescue an overbroad promise.
What Each Type of Study Can Support
Instrumental testing
Instrumental methods measure a defined physical or optical parameter. A corneometer-type device can assess capacitance associated with surface hydration. Tewameter-type methods estimate transepidermal water loss under controlled conditions. Cutometry can examine mechanical response associated with firmness or elasticity. Profilometry and standardized imaging can quantify aspects of lines, roughness, color, or radiance.
An instrument does not make a claim automatically objective. The study still needs a relevant endpoint, calibrated equipment, controlled environment, trained operator, suitable subjects, defined acclimation, consistent application, appropriate time points, and a statistical plan. The measured parameter should also match the wording. A change in a hydration reading is not proof that a product rebuilt the skin barrier, and a change in image brightness is not automatically the same as treating pigmentation.
Clinical or expert grading
A trained grader may evaluate visible attributes such as dryness, roughness, fine-line appearance, radiance, or redness using a predefined scale and standardized conditions. This can reflect appearance more directly than some instruments, but it introduces observer judgment. Blinding, grader training, repeatability, standardized photography, and clear scales improve credibility.
The word “clinical” should not be used as decoration. A clinical-use study may be well designed or weak; the label alone does not reveal control group, sample size, duration, investigator independence, or whether the endpoint was defined before the data were collected.
Consumer-perception studies
Consumer studies answer questions about perceived experience: softness, smoothness, comfort, absorption, appearance, ease of use, or satisfaction. They are especially valuable when the benefit is inherently sensory. The result should be reported honestly, such as “90% agreed skin felt softer,” with the population, timing, and number of participants available where appropriate.
A perception study is not interchangeable with an objective measurement. Participants saying that skin felt firmer does not prove a structural change. Question wording matters: leading, double-barreled, vague, or selectively reported questions can make an impressive percentage less meaningful.
In-vitro and ex-vivo research
Cell models, reconstructed skin, biochemical assays, and human-skin explants can help explore mechanisms, screen formulas, or compare ingredient activity under controlled conditions. They are valuable development tools. They usually cannot, by themselves, establish what a consumer will see or feel from customary use of the retail product.
A 2025 serum study illustrates how evidence layers can be combined: laboratory assays, reconstructed-skin and explant work, instrumental measurements, assessor evaluations, and human use were included. The lesson is not that every product needs every method. It is that each method answers a different question and conclusions should remain tied to the tested formula and design.
Study Design Details That Change the Meaning
Finished product versus ingredient
Supplier data can support ingredient selection and explain rationale, but finished-product claims should reflect the marketed formula whenever the claim refers to the product’s performance. Vehicle, concentration, packaging, application, and interactions among ingredients can change the outcome.
Control, baseline, and comparison
A before-and-after study may show change from baseline, but it cannot always separate product effects from season, routine changes, regression to the mean, or normal variation. Vehicle controls, untreated sites, split-face designs, or benchmark products can strengthen inference when practical. A superiority claim requires a study designed for the comparison; two separate supplier studies are not a head-to-head test.
Population and use conditions
Subjects should resemble the people addressed by the claim. Age range, skin type, baseline condition, climate, washout, concurrent products, application amount, and adherence all affect relevance. Evidence from 25 participants with mild dryness should not be stretched into a universal claim for all skin types or a medical-condition claim.
Statistical significance and practical relevance
A statistically significant difference can be small. A visibly meaningful improvement may vary across people. Brands should examine the magnitude of change, variability, responder distribution, method precision, and whether the result supports the consumer-facing wording. Selecting only the most flattering time point after reviewing the data can also misrepresent the study.
Duration and durability
Immediate hydration, cumulative improvement, and persistence after discontinuation are different claims. Study visits should match the proposed timeline. If a product is tested after four weeks of twice-daily use, the marketing should not imply a one-use result or a benefit that lasts after consumers stop applying it.
Safety Testing Is Not Performance Claims Testing
Safety substantiation, stability, preservative efficacy, compatibility, and tolerability are essential, but they answer different questions from efficacy or perception studies. A repeat-insult patch test may contribute information about irritation or sensitization under study conditions; it does not prove that a moisturizer hydrates for 24 hours. A stability study supports physical and chemical quality over time; it does not prove visible wrinkle reduction.
FDA notes that it does not prescribe one universal list of tests for each cosmetic, while companies remain responsible for product safety. Under MoCRA, the responsible person must ensure and maintain records supporting adequate safety substantiation. Founders should keep the safety file and performance-claims file coordinated but conceptually separate.
Connecting Claims Testing to Private-Label Skincare Development
In a white-label or private-label program, ask which evidence applies to the exact formula and package being offered. Supplier literature, raw-material studies, and testing on a related formula can be useful context, but they should be labeled accurately. If a brand changes fragrance, active level, package dose, directions, or other meaningful features, it should assess whether existing support still fits.
Custom formulation gives founders the opportunity to design toward a claim, but the brief must be specific. A request for “clinically proven anti-aging” is too broad. A better brief might prioritize immediate and eight-hour hydration, improved appearance of fine dryness lines after four weeks, and strong consumer ratings for absorption and comfort. The formulator can then balance ingredients, sensory design, packaging, and testing feasibility around those targets.
Derma Essentials Lab can help connect the product brief, formula, manufacturing process, packaging, and external testing plan so the claims strategy develops alongside the product rather than after production.
What Skincare Brand Founders Should Consider
- Write the exact claim first, including timing, population, body area, use frequency, and comparison.
- Choose the evidence type that measures the promised outcome rather than the most impressive-sounding test.
- Confirm that the marketed formula, directions, and package match what was tested.
- Review controls, sample size, duration, inclusion criteria, blinding, endpoints, and statistical plan before the study begins.
- Keep ingredient data, laboratory mechanisms, safety evidence, instrumental results, expert grading, and consumer perception in their proper categories.
- Plan how the result will appear on the label, website, retailer page, social media, and influencer materials so the full message remains accurate.
Build Claims That Can Survive a Close Read
Good claims testing does more than supply a percentage for an advertisement. It helps a brand define what the product does, for whom, under what conditions, and on what evidence. That clarity improves the product brief, reduces last-minute copy changes, and gives customers a more trustworthy reason to buy.
Derma Essentials Lab supports founders from formula selection and custom development through packaging and manufacturing. When a product needs performance claims, the team can help align development decisions with an appropriate external testing and documentation plan before launch.
Sources and References
- Federal Trade Commission. FTC Policy Statement Regarding Advertising Substantiation.
- Federal Trade Commission. Health Products Compliance Guidance.
- U.S. Food and Drug Administration. Cosmetics Labeling Claims.
- U.S. Food and Drug Administration. Product Testing of Cosmetics.
- Goswami S, et al. In Vitro, Ex Vivo, Instrumental, and Clinical Assessment of a Novel Anti-aging Serum Targeting Oxidative Stress. Journal of Cosmetic Dermatology. 2025.
0 comments